Reposted by Sarahdja CORNÉLIE
Excessive Ca²⁺ signaling fuels inflammation in a zebrafish model of #cysticfibrosis, and verapamil, an FDA-approved Ca²⁺ channel blocker, restores balance & limits inflammation, new study reveals. A promising repurposing opportunity for CF therapy!
📖 shorturl.at/Fxg9F
✍️ @sarahdja.bsky.social & coll.